Jean S. Beebe

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

Bruce D. Cohen, Deborah A. Baker, Catherine Soderstrom et al. · Clinical Cancer Research · 2005 · 362 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis

Melinda Gooderham, Seth Forman, Robert Bissonnette et al. · JAMA Dermatology · 2019 · 237 citations · Full text

Medicine, Dermatology, Pharmacology +11

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Silvio Danese, Séverine Vermeire, Paul Hellstern et al. · Gut · 2017 · 178 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Increased Serum Enzyme Levels Associated with Kupffer Cell Reduction with No Signs of Hepatic or Skeletal Muscle Injury

Zaher A. Radi, Petra Koza‐Taylor, R. R. Bell et al. · American Journal Of Pathology · 2011 · 139 citations · Full text

Life Sciences, Immunology, Physiology +17

Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial

Daniel J. Wallace, Vibeke Strand, Joan T. Merrill et al. · Annals of the Rheumatic Diseases · 2016 · 133 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15